Kivu BIoscience

IN THE PRESS

Press Releases

Kivu Bioscience Appoints Sophia Randolph, M.D., Ph.D., as Chief Medical Officer

October 28, 2025

·

2 min read

Press Releases

Kivu Bioscience Presents Preclinical Data for KIVU-107 Demonstrating Potent and Durable Anti-Tumor Activity and a Wide Therapeutic Index at World ADC San Diego 2025

October 21, 2025

·

3 min read

Press Releases

Kivu Bioscience Selects Sterling Pharma Solutions for cGMP Manufacturing of Lead Oncology Antibody-Drug Conjugate KIVU-107

June 2, 2025

·

3 min read

Press Releases

Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates

October 28, 2024

·

4 min read

JOBS